TIGIT binds to CD155, an overexpressed ligand in tumor and stromal cells within the TME, transmitting inhibitory signals through its immunoreceptor tyrosine-based inhibitory motif (ITIM). The gene discussed is TIGIT; the disease is neoplasm.